These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 448074

  • 1. Action of the C3b-inactivator on the cell-bound C3b.
    Law SK, Fearon DT, Levine RP.
    J Immunol; 1979 Mar; 122(3):759-65. PubMed ID: 448074
    [Abstract] [Full Text] [Related]

  • 2. Complement receptor binding of C3b-coated cells treated with C3b inactivator, beta 1H globulin and trypsin.
    Carlo JR, Ruddy S, Studer EJ, Conrad DH.
    J Immunol; 1979 Aug; 123(2):523-8. PubMed ID: 88474
    [Abstract] [Full Text] [Related]

  • 3. Qualitative and quantitative assessment of C3-receptor reactivities on lymphoid and phagocytic cells.
    Schmitt M, Mussel HH, Dierich MP.
    J Immunol; 1981 May; 126(5):2042-7. PubMed ID: 7217681
    [Abstract] [Full Text] [Related]

  • 4. Role of human factor I and C3b receptor in the cleavage of surface-bound C3bi molecules.
    Medicus RG, Melamed J, Arnaout MA.
    Eur J Immunol; 1983 Jun; 13(6):465-70. PubMed ID: 6222909
    [Abstract] [Full Text] [Related]

  • 5. Human complement C3b inactivator: isolation, characterization, and demonstration of an absolute requirement for the serum protein beta1H for cleavage of C3b and C4b in solution.
    Pangburn MK, Schreiber RD, Müller-Eberhard HJ.
    J Exp Med; 1977 Jul 01; 146(1):257-70. PubMed ID: 301546
    [Abstract] [Full Text] [Related]

  • 6. Cleavage of C4b by C3b inactivator: production of a nicked form of C4b, C4b', as an intermediate cleavage product of C4b by C3b inactivator.
    Nagasawa S, Ichihara C, Stroud RM.
    J Immunol; 1980 Aug 01; 125(2):578-82. PubMed ID: 7391570
    [Abstract] [Full Text] [Related]

  • 7. Inhibitory effect of K-76 monocarboxylic acid, an anticomplementary agent, on the C3b inactivator system.
    Hong K, Kinoshita T, Kitajima H, Inoue K.
    J Immunol; 1981 Jul 01; 127(1):104-8. PubMed ID: 7240739
    [Abstract] [Full Text] [Related]

  • 8. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE, Harrison RA, Lachmann PJ.
    J Immunol; 1984 Apr 01; 132(4):1960-6. PubMed ID: 6607952
    [Abstract] [Full Text] [Related]

  • 9. Relative importance of C3b inactivator and beta 1H globulin in the modulation of the properdin amplification loop in systemic lupus erythematosus.
    Whaley K, Schur PH, Ruddy S.
    Clin Exp Immunol; 1979 Jun 01; 36(3):408-14. PubMed ID: 114347
    [Abstract] [Full Text] [Related]

  • 10. Mouse C3b/C4b inactivator: purification and properties.
    Kai S, Fujita T, Gigli I, Nussenzweig V.
    J Immunol; 1980 Dec 01; 125(6):2409-15. PubMed ID: 6776193
    [Abstract] [Full Text] [Related]

  • 11. Molecular basis of complement resistance of human melanoma cells expressing the C3-cleaving membrane protease p65.
    Ollert MW, Kadlec JV, Petrella EC, Bredehorst R, Vogel CW.
    Cancer Res; 1993 Feb 01; 53(3):592-9. PubMed ID: 8425193
    [Abstract] [Full Text] [Related]

  • 12. Third component of complement (C3): structural properties in relation to functions.
    Bokisch VA, Dierich MP, Mūller-Eberhard HJ.
    Proc Natl Acad Sci U S A; 1975 Jun 01; 72(6):1989-93. PubMed ID: 1056006
    [Abstract] [Full Text] [Related]

  • 13. C3b inactivator in the rheumatic diseases. Measurement by radial immunodiffusion and by inhibition of formation of properdin pathway C3 convertase.
    Whaley K, Schur PH, Ruddy S.
    J Clin Invest; 1976 Jun 01; 57(6):1554-63. PubMed ID: 819459
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Receptor-binding sites on C3 and C3b.
    Dierich MP, Bokisch VA.
    J Immunol; 1977 Jun 01; 118(6):2145-50. PubMed ID: 864256
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.